“…We present a case of glycemic pattern documented on CGM of a patient with type 2 diabetes, who had received 11 cycles of a single dose Dexamethasone-containing chemotherapy. Clinical Case: The patent is 70 years old female with history of type 2 DM of 19 years duration and metastatic pancreatic adenocarcinoma, diagnosed in November 2018, and treated with Fluorouracil and Dexamethasone 6mg IV on every other Wednesday since December 2018. …”
Enlace del recurso
Enlace del recurso

“…The study included seven treatments with four replicates, which used 0% (control, CON), 5%, 10%, 15%, 20%, 25% and 30% cassava residue to replace crushed maize (air-dried matter basis), respectively. A China-patented automated trace gas recording system was used to perform in vitro gas tests; rumen fluids were collected from three dairy cows at mid-lactation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Insufficient supply of D-borneol has hampered its clinical use and production of patent remedies for a long time. Biological synthesis of D-borneol offers an additional approach; however, mechanisms of D-borneol biosynthesis remain mostly unresolved. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Headache was most enriched in patents aged 15 to 39 years, followed by those aged 40 to 64 years, with statistical significance. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Lastly, 59% of the patients received treatment, including antiviral, antibiotics, and Chinese patent medicine, before admission. This situation might have some effects on symptoms, such as fever and dry cough. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Crowe, Jr, MD, IDBiologics (Board Member, Consultant, Grant/Research Support)Vanderbilt University (Other Financial or Material Support, Inventor on patent related to this abstract)…”
Enlace del recurso
Enlace del recurso

“…Single (OR, 1.23, 95% CI: 1.03 to 1.54, p = 0.01), poor family function (OR, 1.21, 95% CI: 1.05 to 1.45, p = 0.03), and ≥20mm(3) infarct size (OR, 1.74, 95% CI: 1.14 to 3.13, p = 0.02) were independent factors for having depression in patents with psychological symptoms. The family dysfunction (OR, 2.32, 95% CI: 1.51 to 2.80, p < 0.01) and hypertension (OR, 2.41, 95% CI: 1.54 to 3.46, p = 0.03) were independent factors for emerging somatization and anxiety in patients with psychological symptoms, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This interesting observation has to be confirmed in more patients with CNC and PPNAD to further elucidate the effects of SSRIs on cortisol production in patents with PPNAD-caused Cushing syndrome, as this may have significant diagnostic and therapeutic implications.…”
Enlace del recurso
Enlace del recurso

“…Access ligation was considered by 15 out of 83 (18.1%) patients with a patent VA. Conclusions: In the majority of the patients, vascular access blood flow was below the threshold of the negative cardiovascular effect of vascular access. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Traditional Chinese medicine injections (TCMIs) are common traditional Chinese-patent medicine preparations in China. There was a lack of evidence to prove which TCMIs combine with ADs (TCMIs+ADs) may be a therapeutic option for HN. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…More than half of the MERS-CoV patents showed abnormal chest X-ray, elevated aspartate aminotransferase, and creatinine kinase. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In the present study, blood samples were collected from 6 patients with patent ductus arteriosus. The experimental group included 3 patients with severe PAH, while the control group included 3 patients without PAH. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Compound Taxus chinensis capsule (CTCC), an antitumor Chinese patent medicine, has been commonly prescribed as an adjunctive agent to chemotherapy for the management of non-small-cell lung cancer (NSCLC); however, the effects of CTCC added to chemotherapy for NSCLC patients have never been comprehensively evaluated or summarized. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We assessed the frequency and percent of articles by journal, collecting variables including impact factor, AAS, along with average mentions within news, blogs, policy, patents, Twitter, peer review, Weibo, Facebook, Wikipedia, Google+, LinkedIn, Reddit, Pinterest, F1000, Q&A, online video, Syllabi, and traditional metrics such as number of Mendeley readers and citations (Table 1). …”
Enlace del recurso
Enlace del recurso

“…Nutrient repletion therapy should be a fundamental strategy to restore the healthy properties of blood. A unique patent-pending iron-free VMP35 formulation was engineered by our laboratory to restore iron-dependent hemoglobin in anemic cells using a proprietary Prodosome(®) absorption technology. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The plasma levels of bone metabolic markers, 25-hydroxyvitamin D (25-(OH)VitD), propeptide of type I procollagen (PINP), and β-Carboxyl terminal peptide (β-CTx), were detected using the patented electro-chemiluminescence (ECLIA) method. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Effective therapies for PGF are inconclusive. New Chinese patent medicine Pai-Neng-Da (PND) Capsule exerts dual effect in promoting hematopoiesis recovery and regulating immunity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Meanwhile, researchers found no significant difference between the colostrum group and control group in the incidence of bronchopulmonary dysplasia (BPD; p = 0.17, RR = 0.83, 95% CI = 0.64–1.08), intraventricular hemorrhage (IVH; grade ≥3; p = 0.05, RR = 0.44, 95% CI = 0.19–1.01), periventricular leukomalacia (PVL; p = 0.67, RR = 0.70, 95% CI = 0.14–3.49), retinopathy of prematurity (ROP; p = 0.29, RR = 1.25, 95% CI = 0.82–1.89), and patent ductus arteriosus (PDA; p = 0.17, RR = 1.22, 95% CI = 0.92–1.62). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The difference in LF morphology is consistent in patient’s ≥ 40 years of age among the groups as found in subgroup analysis. Similarly in the patents < 40 and > 40 in the non-LCS group. CONCLUSION: LF is vital in the pathogenesis of LCS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: This prospective cohort study enrolled 290 consecutive pediatric patients who underwent ventricular septal defects (VSD), atrial septal defects (ASD), and patent ductus arteriosus (PDA) between February 2019 and December 2020. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso